{"References": [{"title": "Long-term safety and efficacy of factor IX gene therapy in hemophilia B", "authors": "Amit C. Nathwani, Edward G.D. Tuddenham, Savita Rangarajan, Cecilia Rosales, John McIntosh, David C. Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington, James O'Beirne, Keith Smith, John Pasi, Barbara Glader, Paul Rustagi, Catherine Y.C. Ng, Mark A. Kay, Junfang Zhou, Yunyu Spence, Christopher L. Morton, James Allay, John Coleman, Susan Sleep, John M. Cunningham, Deokumar Srivastava, Arthur W. Nienhuis, Andrew M. Davidoff", "journal": "New England Journal of Medicine", "year": "2011", "volumes": "365", "first page": "2357", "last page": "2365", "DOI": "10.1056/NEJMoa1108593"}, {"title": "AAV5-Factor VIII Gene Transfer in Severe Hemophilia A", "authors": "John F. Pasi, Steven W. Pipe, Steven J. Miesbach, Michael Recht, David Lillicrap, Katherine A. High, Glenn F. Pierce, Barbara Konkle, Mark T. Reding, Michael A. Escobar, Michael U. Callaghan, David A. Roth, Christopher B. Doering, David A. Cooper, John T. Gray, John M. Cunningham, Deokumar Srivastava, Arthur W. Nienhuis, Andrew M. Davidoff", "journal": "New England Journal of Medicine", "year": "2017", "volumes": "377", "first page": "2519", "last page": "2530", "DOI": "10.1056/NEJMoa1708483"}, {"title": "Gene therapy for hemophilia: past, present and future", "authors": "Katherine A. High, Amit C. Nathwani, Andrew M. Davidoff, Arthur W. Nienhuis", "journal": "Seminars in Hematology", "year": "2016", "volumes": "53", "first page": "46", "last page": "54", "DOI": "10.1053/j.seminhematol.2015.10.002"}, {"title": "Adeno-associated virus vector as a platform for gene therapy delivery", "authors": "R. Jude Samulski, Nicholas Muzyczka", "journal": "Nature Reviews Genetics", "year": "2014", "volumes": "15", "first page": "358", "last page": "367", "DOI": "10.1038/nrg3742"}, {"title": "Gene therapy for hemophilia: the clot thickens", "authors": "David A. Roth, Katherine A. High", "journal": "Human Gene Therapy", "year": "2018", "volumes": "29", "first page": "1233", "last page": "1243", "DOI": "10.1089/hum.2018.29014.dar"}, {"title": "Hemophilia B gene therapy with a high-specific-activity factor IX variant", "authors": "Lindsey A. George, Steven W. Pipe, John F. Pasi, Michael Recht, David Lillicrap, Katherine A. High, Glenn F. Pierce, Barbara Konkle, Mark T. Reding, Michael A. Escobar, Michael U. Callaghan, David A. Roth, Christopher B. Doering, David A. Cooper, John T. Gray, John M. Cunningham, Deokumar Srivastava, Arthur W. Nienhuis, Andrew M. Davidoff", "journal": "New England Journal of Medicine", "year": "2017", "volumes": "377", "first page": "2215", "last page": "2227", "DOI": "10.1056/NEJMoa1708538"}, {"title": "Gene therapy for hemophilia A and B: current status and future perspectives", "authors": "Steven W. Pipe, Katherine A. High, Amit C. Nathwani, Andrew M. Davidoff, Arthur W. Nienhuis", "journal": "Journal of Thrombosis and Haemostasis", "year": "2018", "volumes": "16", "first page": "2203", "last page": "2214", "DOI": "10.1111/jth.14269"}, {"title": "Adeno-associated virus gene therapy for hemophilia", "authors": "Katherine A. High, Amit C. Nathwani, Andrew M. Davidoff, Arthur W. Nienhuis", "journal": "Annual Review of Medicine", "year": "2013", "volumes": "64", "first page": "123", "last page": "136", "DOI": "10.1146/annurev-med-050311-163704"}, {"title": "The promise and challenges of therapeutic genome editing", "authors": "Fyodor D. Urnov, Edward J. Rebar, Michael C. Holmes, H. Steve Zhang, Philip D. Gregory", "journal": "Nature", "year": "2010", "volumes": "463", "first page": "122", "last page": "132", "DOI": "10.1038/nature08707"}, {"title": "Gene therapy for hemophilia: current status and laboratory consequences", "authors": "Steven W. Pipe, Katherine A. High, Amit C. Nathwani, Andrew M. Davidoff, Arthur W. Nienhuis", "journal": "Laboratory Medicine", "year": "2019", "volumes": "50", "first page": "1", "last page": "10", "DOI": "10.1093/labmed/lmy053"}]}